Logo image of XPEV

XPENG INC - ADR (XPEV) Stock Fundamental Analysis

USA - NYSE:XPEV - US98422D1054 - ADR

21.66 USD
+0.37 (+1.74%)
Last: 9/19/2025, 8:04:00 PM
21.44 USD
-0.22 (-1.02%)
Pre-Market: 9/22/2025, 4:44:37 AM
Fundamental Rating

3

Overall XPEV gets a fundamental rating of 3 out of 10. We evaluated XPEV against 37 industry peers in the Automobiles industry. XPEV may be in some trouble as it scores bad on both profitability and health. XPEV is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

XPEV had negative earnings in the past year.
In the past 5 years XPEV always reported negative net income.
XPEV had negative operating cash flow in 4 of the past 5 years.
XPEV Yearly Net Income VS EBIT VS OCF VS FCFXPEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B -8B -10B

1.2 Ratios

XPEV has a Return On Assets of -4.63%. This is in the better half of the industry: XPEV outperforms 70.27% of its industry peers.
With a decent Return On Equity value of -14.11%, XPEV is doing good in the industry, outperforming 64.86% of the companies in the same industry.
Industry RankSector Rank
ROA -4.63%
ROE -14.11%
ROIC N/A
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.51%
ROIC(3y)N/A
ROIC(5y)N/A
XPEV Yearly ROA, ROE, ROICXPEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

XPEV has a better Gross Margin (15.74%) than 62.16% of its industry peers.
XPEV's Gross Margin has improved in the last couple of years.
XPEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.05%
GM growth 5YN/A
XPEV Yearly Profit, Operating, Gross MarginsXPEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
XPEV has more shares outstanding than it did 1 year ago.
XPEV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, XPEV has a worse debt to assets ratio.
XPEV Yearly Shares OutstandingXPEV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
XPEV Yearly Total Debt VS Total AssetsXPEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that XPEV is in the distress zone and has some risk of bankruptcy.
XPEV's Altman-Z score of 1.32 is fine compared to the rest of the industry. XPEV outperforms 64.86% of its industry peers.
XPEV has a Debt/Equity ratio of 0.78. This is a neutral value indicating XPEV is somewhat dependend on debt financing.
XPEV has a Debt to Equity ratio (0.78) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC7.87%
XPEV Yearly LT Debt VS Equity VS FCFXPEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.14 indicates that XPEV should not have too much problems paying its short term obligations.
The Current ratio of XPEV (1.14) is comparable to the rest of the industry.
A Quick Ratio of 1.00 indicates that XPEV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, XPEV is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1
XPEV Yearly Current Assets VS Current LiabilitesXPEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

More info and screens

7

3. Growth

3.1 Past

XPEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.92%, which is quite impressive.
The Revenue has grown by 66.37% in the past year. This is a very strong growth!
XPEV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 77.48% yearly.
EPS 1Y (TTM)48.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.24%
Revenue 1Y (TTM)66.37%
Revenue growth 3Y24.87%
Revenue growth 5Y77.48%
Sales Q2Q%125.29%

3.2 Future

XPEV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.29% yearly.
The Revenue is expected to grow by 30.82% on average over the next years. This is a very strong growth
EPS Next Y73.2%
EPS Next 2Y49.37%
EPS Next 3Y37.77%
EPS Next 5Y23.29%
Revenue Next Year95.57%
Revenue Next 2Y65.2%
Revenue Next 3Y46.06%
Revenue Next 5Y30.82%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XPEV Yearly Revenue VS EstimatesXPEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50B 100B 150B 200B
XPEV Yearly EPS VS EstimatesXPEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XPEV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 109.13 indicates a quite expensive valuation of XPEV.
64.86% of the companies in the same industry are more expensive than XPEV, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, XPEV is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 109.13
XPEV Price Earnings VS Forward Price EarningsXPEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPEV Per share dataXPEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as XPEV's earnings are expected to grow with 37.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.37%
EPS Next 3Y37.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPEV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPENG INC - ADR

NYSE:XPEV (9/19/2025, 8:04:00 PM)

Premarket: 21.44 -0.22 (-1.02%)

21.66

+0.37 (+1.74%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-19 2025-08-19/bmo
Earnings (Next)11-17 2025-11-17/bmo
Inst Owners15.84%
Inst Owner Change-7.73%
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap20.62B
Analysts78.18
Price Target25.79 (19.07%)
Short Float %10.8%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.32%
Min EPS beat(2)34.81%
Max EPS beat(2)47.83%
EPS beat(4)2
Avg EPS beat(4)18.11%
Min EPS beat(4)-8.69%
Max EPS beat(4)47.83%
EPS beat(8)4
Avg EPS beat(8)16.95%
EPS beat(12)4
Avg EPS beat(12)3.67%
EPS beat(16)6
Avg EPS beat(16)-1.04%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.52%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)2.52%
Revenue beat(8)2
Avg Revenue beat(8)-2.74%
Revenue beat(12)2
Avg Revenue beat(12)-5.64%
Revenue beat(16)5
Avg Revenue beat(16)-2.91%
PT rev (1m)3.16%
PT rev (3m)4.12%
EPS NQ rev (1m)36.3%
EPS NQ rev (3m)7.19%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.8%
Revenue NQ rev (1m)-1.58%
Revenue NQ rev (3m)-2.53%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 109.13
P/S 2.43
P/FCF N/A
P/OCF N/A
P/B 4.84
P/tB 5.64
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)0.2
Fwd EY0.92%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.9
BVpS4.48
TBVpS3.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -14.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.74%
FCFM N/A
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.05%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1
Altman-Z 1.32
F-ScoreN/A
WACC7.87%
ROIC/WACCN/A
Cap/Depr(3y)220.75%
Cap/Depr(5y)357.28%
Cap/Sales(3y)10.3%
Cap/Sales(5y)14.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.24%
EPS Next Y73.2%
EPS Next 2Y49.37%
EPS Next 3Y37.77%
EPS Next 5Y23.29%
Revenue 1Y (TTM)66.37%
Revenue growth 3Y24.87%
Revenue growth 5Y77.48%
Sales Q2Q%125.29%
Revenue Next Year95.57%
Revenue Next 2Y65.2%
Revenue Next 3Y46.06%
Revenue Next 5Y30.82%
EBIT growth 1Y22.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.93%
EBIT Next 3Y43.04%
EBIT Next 5Y30.46%
FCF growth 1Y-227.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-310.46%
OCF growth 3YN/A
OCF growth 5YN/A